Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

Millennials: the wellness generation

Millennials: the wellness generation

Living a good quality life, rather than as long a life as possible, is important to more people in the UK (43%), US and Japan (both 42%) compared to those in ... This is compared to 64% in the US, 54% in the UK, 50% in Japan and 44% in Germany.

AstraZeneca’s Truqap plus Faslodex receives FDA approval for advanced breast cancer

AstraZeneca’s Truqap plus Faslodex receives FDA approval for advanced breast cancer Regulatory applications for Truqap, which was discovered by AZ subsequent to a collaboration with Astex Therapeutics, in combination with Faslodex are also currently under review in the EU, China, Japan and

Pfizer’s Litfulo approved by MHRA for adults and adolescents with alopecia areata

Pfizer’s Litfulo approved by MHRA for adults and adolescents with alopecia areata The drug has already been approved in the US and Japan for the same patient population and is being evaluated for potential additional indications, including non-segmental vitiligo.

Roche to acquire Telavant in deal worth over $7.1bn

Roche to acquire Telavant in deal worth over $7.1bn Roche will gain the rights to develop, manufacture and commercialise RVT-3101 in the US and Japan pending clinical and regulatory success and, in addition to the $7.1bn upfront, will

Merck and Daiichi Sankyo announce ADC agreement worth up to $22bn

Merck and Daiichi Sankyo announce ADC agreement worth up to $22bn The companies will jointly develop and potentially commercialise the ADC candidates worldwide, except in Japan, where Daiichi Sankyo will maintain exclusive rights.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM

AMICULUM is an independent family of 11 branded agencies that deliver communications and consultancy services to pharmaceutical, biotechnology and health...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...